These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17462514)

  • 1. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians.
    Chatterjee A; Rathore A; Dhole TN
    J Med Virol; 2009 Jun; 81(6):959-65. PubMed ID: 19382262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
    Gupta A; Padh H
    Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].
    Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
    Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
    J Med Virol; 2008 Jul; 80(7):1133-41. PubMed ID: 18461620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
    Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
    Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
    Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
    Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.